Vigilant Biosciences
Biotechnology Research • 
Lakeway, Texas, United States • 11-20 Employees
Company overview
| Headquarters | 1008 Ranch Road 620, Suite 204, Lakeway , TX 78734, US |
| Phone number | +13057285832 |
| Website | |
| NAICS | 541714 |
| SIC | 873 |
| Keywords | Biotechnology, Diagnostics, Oncology |
| Founded | 2011 |
| Employees | 11-20 |
| Socials |
Key Contacts at Vigilant Biosciences
Bill Brodie
Ceo
Elizabeth Franzmann
Scientific Founder And Scientific Adviser
Alvin James
Director Of Quality And Manufacturing
Kristi Valentine
Global Director Of Clinical Relations
Jason Sanders
Senior Director Of Operations
Dex Manley
Senior Director Software Systems
Cinthia Gaona
Director, Ra/Qa & Program Management
Brian Hansen
Director Of Engineering, System Test
Vigilant Biosciences Email Formats
Vigilant Biosciences uses 3 email formats. The most common is {first initial}.{last name} (e.g., j.doe@vigilantbiosciences.com), used 71.4% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}.{last name} | j.doe@vigilantbiosciences.com | 78.5% |
{first name}.{last name} | john.doe@vigilantbiosciences.com | 21.4% |
About Vigilant Biosciences
Vigilant Biosciences is a leading innovator and developer of solutions that aid clinicians in the early detection of cancer. The BeVigilant™ OraFusion System aids clinicians with identifying patients at risk for oral cancers. It is simple, accurate and cost-effective, empowering healthcare practitioners to improve lives through earlier intervention. The BeVigilant™ OraFusion System, the first and only technology that measures tumor-initiating and stem cell associated biomarkers – markers clinically validated to be associated with oral cancer – was developed to aid clinicians in the early detection of oral cancer. The point-of-care BeVigilant™ OraFusion System uses a simple collection method that is easy to administer and non-invasive for the patient. The test has the potential to benefit adults at risk of oral cancer, with particular emphasis on high-risk populations (i.e., current and former tobacco users, those who consume excessive alcohol, and people with human papillomavirus, HPV-16). The BeVigilant™ OraFusion System is CE Marked and available in select markets outside of the United States. The BeVigilant™ OraFusion System is not available for sale in the U.S. Leadership: Bill Brodie, Chief Executive Officer Robert T. Hamilton, CPA, Chief Financial Officer Dragan Nebrigic, Ph.D., Chief Operating Officer Ben Beckham, Chief Commercial Officer Michael Donovan, M.D. Ph.D., Chief Clinical Officer
Vigilant Biosciences revenue & valuation
| Annual revenue | $5,000,000 |
| Revenue per employee | $250,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $16,000,000 |
| Total funding | $2,400,000 |
Employees by Management Level
Total employees: 11-20
Seniority
Employees
Employees by Department
Vigilant Biosciences has 8 employees across 6 departments.
Departments
Number of employees
Vigilant Biosciences Tech Stack
Discover the technologies and tools that power Vigilant Biosciences's digital infrastructure, from frameworks to analytics platforms.
Video players
Security
Caching
Mobile frameworks
JavaScript libraries
JavaScript libraries
JavaScript libraries
CDN
JavaScript libraries
Analytics
Miscellaneous
Programming languages
India
Spain
United Kingdom
Frequently asked questions
4.8
40,000 users
